National Health (Paraplegic and Quadriplegic Program) Special Arrangement Amendment Instrument 2012 (No. 2) (No. PB 91 of 2012) (Cth)

Case
No judgment structure available for this case.

PB 91 of 2012

National Health (Paraplegic and Quadriplegic Program) Special Arrangement Amendment Instrument 2012 (No.2)[1]

National Health Act 1953

I, KIM BESSELL, First Assistant Secretary (Acting), Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this Instrument under subsections 100(1) and (2) of the National Health Act 1953.

Dated         27  September  2012

KIM BESSELL

First Assistant Secretary (Acting)

Pharmaceutical Benefits Division

Department of Health and Ageing

1       Name of Instrument

(1)This Instrument is the National Health (Paraplegic and Quadriplegic Program) Special Arrangement Amendment Instrument 2012 (No.2).

(2)This Instrument may also be cited as PB 91 of 2012.

2       Commencement

This Instrument commences on 1 October 2012.

3       Amendments to National Health (Paraplegic and Quadriplegic Program) Special Arrangement 2010

Schedule 1 amends the National Health (Paraplegic and Quadriplegic Program) Special Arrangement 2010 (PB 118 of 2010)

.

Schedule 1     Amendments

Section 3

[1]           Section 3, Note

Omit:

·     approved price to pharmacists

Insert (in alphabetical order):

·     approved ex-manufacturer price

·     claimed price

·     pack quantity

·     proportional ex-manufacturer price

[2]           Omit section 8

[3]           Subsection 14(1)

Insert after ‘supplies’:

a pack quantity of

[4]           Subsection 14(2)

Omit the subsection.

Insert:

(2)        For subsection (1), the amount is:

(a)     if there is no claimed price for the pack quantity of the pharmaceutical benefit:

(i) the price to pharmacists for the pack quantity worked out under the determination under paragraph 98B(1)(a) of the Act; and

(ii)     a handling fee of 2.75% of that amount; or

(b)     if there is a claimed price for the pack quantity of the pharmaceutical benefit:

(i)      the claimed price for the pack quantity  plus a wholesale mark-up calculated in accordance with subsection (3); and

(ii)     a handling fee of 2.75% of that amount.

(3) For paragraph (2)(b), the wholesale mark‑up for the pack quantity of the pharmaceutical benefit is to be worked out using the methodology for calculating the wholesale mark-up for ready-prepared pharmaceutical benefits in the determination under paragraph 98B(1)(a) of the Act, subject to the following:

(a)     for the purposes of identifying the appropriate wholesale mark-up formula in Step 2 of the methodology, the ex-manufacturer price for the relevant quantity is to be worked out proportionately from the approved ex‑manufacturer price or proportional ex-manufacturer price for the pack quantity of the pharmaceutical benefit; and

(b)     otherwise, the methodology is to be applied as if the claimed price for the pack quantity of the pharmaceutical benefit were the approved ex‑manufacturer price or proportional ex‑manufacturer price for the pack quantity.

[5]       Schedule 1

Omit the Schedule.

Insert:

Schedule 1     Pharmaceutical benefits covered by this Special Arrangement and related information

(sections 4, 6 and 11)

Listed Drug

Form

Manner of Administration

Brand

Responsible Person

Maximum Amount

Bisacodyl Tablet, 5mg oral Bisalax AS 400
Lax‑Tab AE

400

Suppositories 10mg, 10 rectal Dulcolax BY 9
Petrus Bisacodyl Suppositories PP 9
Suppositories 10mg, 12 rectal Petrus Bisacodyl Suppositories PP 8
Enemas 10mg in 5mL, 25 rectal Bisalax AS 2
Glycerol Suppositories 700mg, 12 rectal Petrus Pharmaceuticals Pty Ltd PP 8
Suppositories, 1.4g, 12 rectal Petrus Pharmaceuticals Pty Ltd PP 8
Suppositories 2.8g, 12 rectal Petrus Pharmaceuticals Pty Ltd PP 8
Macrogol 3350 Sachets containing powder for oral solution 13.125g with electrolytes, 30 oral Movicol NE 2
Sorbitol with Sodium Citrate and Sodium Lauryl Sulfoacetate Enemas 3.125g‑450mg‑45mg in 5mL, 12 rectal Micolette AE 4
Microlax JT 4
Sterculia with Frangula Bark Granules 620mg‑80mg, per g, 500g oral Normacol Plus NE 2

[1] Note  All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.See

Actions
Download as PDF Download as Word Document


Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0